Search

Search Results
Results 2991 - 3000 of 8508 for Skin Cancer
  • Rinvoq
    Drug - 21 Jan 2026
    Consumer Medicine Information (CMI) about Rinvoq intended for persons living in Australia.
  • Injectable paste from human skin cells may improve breast reconstruction
    News - 5 Jan 2026
    Removing part or all of the breast during breast cancer treatment is a potential outcome for some people.
  • Eprex
    Drug - 11 Dec 2025
    Consumer Medicine Information (CMI) about Eprex intended for persons living in Australia.
  • Glivec Tablets
    Drug - 12 Nov 2025
    Consumer Medicine Information (CMI) about Glivec Tablets intended for persons living in Australia.
  • Bavencio
    Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Bavencio intended for persons living in Australia.
  • Brenda-35 ED
    Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Brenda-35 ED intended for persons living in Australia.
  • Innovative topical cream relieves chemotherapy-induced peripheral neuropathy
    News - 3 Oct 2025
    Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and feet—a severe side effect that can interfere with proper treatment.
  • Melanoma cases climb amid declining sunscreen use in Canada
    News - 3 May 2025
    Despite decades of public health messaging, Canadians are spending more time in the sun and using less sun protection – raising alarms among researchers as melanoma cases continue to climb.
  • Cotellic
    Drug - 14 Apr 2025
    Consumer Medicine Information (CMI) about Cotellic intended for persons living in Australia.
  • Caprelsa
    Drug - 31 Mar 2025
    Consumer Medicine Information (CMI) about Caprelsa intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback